Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mamsel Pharmaceuticals is a Nigerian pharmaceutical company dedicated to the marketing, sales, and distribution of high-quality and affordable therapeutic products. Established in 2004, the company has built a significant presence in the West African healthcare market by offering a wide portfolio of branded generics. Their product range covers critical areas such as anti-infectives, cardiovascular medicine, analgesics, and gastrointestinal treatments. Mamsel collaborates with international manufacturers to ensure that their products meet global standards of safety and efficacy. The company plays a vital role in the Nigerian healthcare system by bridging the gap between global pharmaceutical production and local patient needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mamsel Pharmaceuticals.